| Symbol | TECH |
|---|---|
| Name | BIO-TECHNE CORP |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Address | 614 MCKINLEY PLACE N.E., MINNEAPOLIS, Minnesota, 55413, United States |
| Telephone | +1 612 379-8854 |
| Fax | — |
| — | |
| Website | https://www.bio-techne.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000842023 |
| Description | Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%. Additional info from NASDAQ: |
New Form PREM14A - BIO-TECHNE Corp <b>Filed:</b> 2026-08-10 <b>AccNo:</b> 0001140361-26-032037 <b>Size:</b> 4 MB
Read moreHippel James 🟡 adjusted position in 566.5K shares (14 derivative) of BIO-TECHNE Corp (TECH) at $120.46 ($41.4M) Transaction Date: Jul 29, 2026 | Filing ID: 000108
Read moreDirector Kelderman Kim 🟡 adjusted position in 720.9K shares (17 derivative) of BIO-TECHNE Corp (TECH) at $120.46 ($40.9M) Transaction Date: Jul 28, 2026 | Filing ID: 000106
Read more